172 related articles for article (PubMed ID: 22394463)
1. RASSF1A Ala133Ser polymorphism is associated with increased susceptibility to hepatocellular carcinoma in a Turkish population.
Bayram S
Gene; 2012 May; 498(2):264-9. PubMed ID: 22394463
[TBL] [Abstract][Full Text] [Related]
2. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
[TBL] [Abstract][Full Text] [Related]
3. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
[TBL] [Abstract][Full Text] [Related]
4. Lack of an association of programmed cell death-1 PD1.3 polymorphism with risk of hepatocellular carcinoma susceptibility in Turkish population: a case-control study.
Bayram S; Akkız H; Ülger Y; Bekar A; Akgöllü E; Yıldırım S
Gene; 2012 Dec; 511(2):308-13. PubMed ID: 23041554
[TBL] [Abstract][Full Text] [Related]
5. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
Bayram S; Akkız H; Bekar A; Akgöllü E
Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
[TBL] [Abstract][Full Text] [Related]
6. No association of the exonuclease 1 T439M polymorphism and risk of hepatocellular carcinoma development in the Turkish population: a case-control study.
Bayram S; Akkiz H; Bekar A; Akgöllü E; Yıldırım S
Asian Pac J Cancer Prev; 2011; 12(9):2455-60. PubMed ID: 22296401
[TBL] [Abstract][Full Text] [Related]
7. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.
Sümbül AT; Akkız H; Bayram S; Bekar A; Akgöllü E; Sandıkçı M
Mol Biol Rep; 2012 Feb; 39(2):1639-47. PubMed ID: 21607615
[TBL] [Abstract][Full Text] [Related]
8. Relationship between functional polymorphism in the Aurora A gene and susceptibility of hepatocellular carcinoma.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ozdil B
J Viral Hepat; 2010 Sep; 17(9):668-74. PubMed ID: 20002563
[TBL] [Abstract][Full Text] [Related]
9. RASSF1A, RECK genotypes and haplotypes in Egyptian population with Hepatocellular carcinoma.
Abd-Elfatah G; Gad-Allah AN
Immunol Lett; 2016 May; 173():36-41. PubMed ID: 26921475
[TBL] [Abstract][Full Text] [Related]
10. Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers.
Dong X; Zhou G; Zhai Y; Zhang H; Yang H; Zhi L; Zhang X; Chu J; He F
Cancer Epidemiol; 2009 Oct; 33(3-4):265-70. PubMed ID: 19766077
[TBL] [Abstract][Full Text] [Related]
11. The significance of Exonuclease 1 K589E polymorphism on hepatocellular carcinoma susceptibility in the Turkish population: a case-control study.
Bayram S; Akkız H; Bekar A; Akgöllü E; Yıldırım S
Mol Biol Rep; 2012 May; 39(5):5943-51. PubMed ID: 22205538
[TBL] [Abstract][Full Text] [Related]
12. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Üsküdar O
Asian Pac J Cancer Prev; 2011; 12(11):3107-12. PubMed ID: 22393998
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphism at codon 133 of the RASSF1 gene is preferentially associated with human lung adenocarcinoma risk.
Kanzaki H; Hanafusa H; Yamamoto H; Yasuda Y; Imai K; Yano M; Aoe M; Shimizu N; Nakachi K; Ouchida M; Shimizu K
Cancer Lett; 2006 Jul; 238(1):128-34. PubMed ID: 16125301
[TBL] [Abstract][Full Text] [Related]
15. Association between RASSF1A Ala133Ser polymorphism and cancer susceptibility: a meta-analysis involving 8,892 subjects.
Bayram S
Asian Pac J Cancer Prev; 2014; 15(8):3691-8. PubMed ID: 24870779
[TBL] [Abstract][Full Text] [Related]
16. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E
Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891
[TBL] [Abstract][Full Text] [Related]
17. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
18. The Association of Ala133Ser Polymorphism and Methylation in Ras Association Domain Family 1A Gene With Unfavorable Prognosis of Hepatocellular Carcinoma.
Feng Y; Li P; Liu Y; Sha Z; Feng L; Wang F; Mao Q; Xue W
Hepat Mon; 2015 Oct; 15(10):e32145. PubMed ID: 26587041
[TBL] [Abstract][Full Text] [Related]
19. Association of genetic polymorphisms in STAT1 gene with increased risk of hepatocellular carcinoma.
Zhu ZZ; Di JZ; Gu WY; Cong WM; Gawron A; Wang Y; Zheng Q; Wang AZ; Zhu G; Zhang P; Hou L
Oncology; 2010; 78(5-6):382-8. PubMed ID: 20798561
[TBL] [Abstract][Full Text] [Related]
20. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ
Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]